The Global Market for Stem Cells

  • ID: 4489399
  • Report
  • Region: Global
  • 162 Pages
  • BCC Research
10 % OFF
until Jun 30th 2018
1 of 5
The Report Includes an Analyses of Global Market Trends, with Data From 2016 and 2017, and Projections of CAGRs Through 2022

FEATURED COMPANIES

  • 3Dmatrix
  • Biotime Inc.
  • Epistem Ltd.
  • Mesoblast Ltd.
  • Primegen Biotech Llc
  • Stempeutics
  • MORE

Report Scope:

This report discusses the implications of stem cell research and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and analyzed by the most important national markets. The important technologies supporting stem cells are reviewed, and the nature and structure of the stem cell industry is discussed, with profiles of the leading companies, including recent merger and acquisition (M&A) activity. Five-year sales forecasts are provided for the national markets and the major therapeutic categories of the products involved.

Report Includes:

  • 42 data tables and 18 additional tables
  • An overview of the global market for stem cells
  • Analyses of global market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • Identification of segments with high growth potential and their future applications
  • Explanation of major drivers and regional dynamics of the market and current trends within the industry
  • Detailed profiles of major vendors in the market, including Cellular Dynamics International, Inc., Celyad, Cytori Therapeutics, Inc., Epistem Ltd. and Gamida-Cell Ltd.

Reasons for Doing the Study:

Products based on stem cells do not yet form an established market, but unlike some other potential applications of bioscience, stem cell technology has already produced many significant products in important therapeutic areas. The potential scope of the stem cell market is now becoming clear, and it is appropriate to review the technology, see its current practical applications, evaluate the participating companies and look to its future.

Membership Price:

Contact us for membership pricing.

READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • 3Dmatrix
  • Biotime Inc.
  • Epistem Ltd.
  • Mesoblast Ltd.
  • Primegen Biotech Llc
  • Stempeutics
  • MORE

1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing the Study
  • Scope of Report
  • Market Analyses and Forecasts
  • Methodology
  • Intended Audience
  • Information Sources
  • Analyst's Credentials
  • Related Research Reports

2 Summary and Highlights

  • Definitions
  • Applications
  • Research and Commercialization
  • Funding
  • Market

3 Overview

  • Cells
  • Stem Cells
  • Induced Pluripotent Stem Cells

4 Stem Cell Research

  • History
  • Embryonic Stem Cells
  • Growth and Identification of Embryonic Stem Cells
  • Stimulating Embryonic Stem Cells to Differentiate
  • Adult Stem Cells
  • Mesechymal Stem Cells
  • Hematopoietic Stem Cells
  • Neural Stem Cell
  • Endothelial Progenitor Cell
  • Epithelial Stem Cell
  • Very Small Embryonic-Like Cell
  • Cord Blood Stem Cells
  • Induced Pluripotent Stem Cells
  • Nuclear Reprogramming
  • Cell-Based Therapeutics
  • Embryonic-Derived Stem Cells
  • Adult and Progenitor-Derived Stem Cells
  • Engineered Stem Cells for Transplantation
  • Therapeutic Stem Cell Banking
  • Stem-Cell-Based Biomedical Research
  • Stem Cell Research Centers
  • Regulation of Stem Cell Research
  • National Regulatory Measures
  • Practicalities of Stem Cell Research and Production
  • Stem Cell Production
  • Stem Cell Acquisition
  • Stem Cell Production Economics
  • Customized Therapy
  • Banks
  • Novel Stem Cell Production Developments
  • Isolation and Engineering
  • Adult Stem Cells
  • Embryonic Stem Cells
  • Induced Pluripotent Stem Cells
  • Bioprinting
  • Stem Cell Banking

5 Stem Cell Applications

  • Regenerative Medicine
  • Current Stem Cell Therapy Applications
  • Cancer
  • Amyotrophic Lateral Sclerosis
  • Parkinson's Disease
  • Spinal Cord Injury
  • Alzheimer's Disease
  • Heart Disease
  • Peripheral Arterial Disease
  • Type 1 Diabetes
  • Orthopedic Repair
  • Liver Failure
  • Graft-Versus-Host Disease
  • Lung Disease

6 Stem Cell Patents

  • General Background on Patents
  • Stem Cell Patents
  • Policies by Country
  • U.S
  • Canada
  • EPC
  • U.K.
  • Germany
  • Japan
  • China
  • Induced Pluripotent Stem Cells
  • Recent Patent Activity

7 Stem Cell Markets

  • Markets for Stem Cells
  • Market Drivers
  • Market Opportunities by Therapeutic Class
  • Cancer
  • Cardiovascular Disease
  • Myocardial Infarction
  • Central Nervous System Disease
  • Spinal Cord Injury
  • Neurodegenerative Diseases
  • Diabetes Mellitus
  • Skeletal System
  • Global Market Estimates and Forecasts
  • Regional and National Market Analysis
  • Americas
  • U.S.
  • Canada
  • Brazil
  • Mexico
  • Europe
  • France
  • Germany
  • Italy
  • Spain
  • U.K.
  • Asia-Pacific
  • Market Opportunities by Disease Category
  • Japan
  • China
  • India
  • Rest of World

8 Company Profiles

  • 3Dmatrix
  • Aldagen Inc.
  • Arteriocyte
  • Athersys Inc.
  • Beike Biotechnology Co. Ltd
  • Biotime Inc.
  • Brainstorm Cell Therapeutics Inc.
  • Caladrius Biosciences Inc.
  • Capricor Inc.
  • Cellerant Therapeutics Inc.
  • Cellular Dynamics International
  • Celyad
  • Cytori Therapeutics Inc.
  • Epistem Ltd.
  • Gamida Cell Ltd.
  • Globalstem
  • Hybrid Organ Gmbh
  • International Stem Cell Corporation
  • Juventas Therapeutics Inc.
  • Mesoblast Ltd.
  • Neurogeneration
  • Ocata
  • Osiris Therapeutics Inc.
  • Primegen Biotech Llc
  • Reneuron Group
  • Rhinocyte Inc.
  • Stem Cells Inc.
  • Stemedica Cell Technologies Inc.
  • Stemina Biomarker Discovery Inc.
  • Stempeutics
  • Tigenix NV
  • U.S. Stem Cell Inc.
  • Vericel Corporation
  • Veristem
  • Viacyte Inc.
  • Vitro Diagnostics Inc.
  • Wicell Research Institute
  • Xpand Biotechnology BV

9 Appendix 1: Glossary

10 Appendix 2: Significant Stem Cell Research Patents

List of Tables
Summary Table : Global Stem Cell Market, by Region, Through 2022
Table 1 : Bioprinting Emerging Platforms
Table 2 : Table 2 Countries Engaged in the ISCBI Program, 2017
Table 3 : Yamanaka’s Induced Pluripotent Stem-Related Patents, 2011
Table 4 : Stem Cell Patents, by Type, 2011
Table 5 : Global Healthcare Systems, 2017
Table 6 : Companies Developing Stem Cell Therapies for Cardiovascular Diseases, 2017
Table 7 : U.S. Statistics for Spinal Cord Injury, 2017
Table 8 : Global Neurodegenerative Diseases, 2015
Table 9 : U.S. Statistics for Diabetes, 2015
Table 10 : Global Market for Diabetes Mellitus, Treatments and Devices, Through 2022
Table 11 : Global Stem Cell Market, by Region, Through 2022
Table 12 : Stem Cell Market, by Country, Through 2022
Table 13 : Potential U.S. Patient Populations for Cell-Based Therapies, 2016
Table 14 : U.S. Stem Cell Therapy Market, Through 2022
Table 15 : U.S. Stem Cell Research and Services Market, Through 2022
Table 16 : U.S. Stem Cell Cord Blood Services Market, Through 2022
Table 17 : Canadian Stem Cell Therapy Market, Through 2022
Table 18 : Canadian Stem Cell Research and Services Market, Through 2022
Table 19 : Canadian Stem Cell Cord Blood Services Market, Through 2022
Table 20 : Brazilian Stem Cell Therapy Market, Through 2022
Table 21 : Brazilian Stem Cell Research and Services Market, Through 2022
Table 22 : Brazilian Stem Cell Cord Blood Services Market, Through 2022
Table 23 : Mexican Stem Cell Therapy Market, Through 2022
Table 24 : Mexican Stem Cell Cord Blood Services Market, Through 2022
Table 25 : European Stem Cell Market, by Country, Through 2022
Table 26 : European Statistics for Cardiovascular Disease, 2017
Table 27 : European Rate of Death from Heart Disease, by Country, 2016
Table 28 : European Statistics for Central Nervous System Disorders and Injuries, 2016
Table 29 : European Statistics for Spinal Cord Injury and Parkinson’s Disease, by Country, 2016
Table 30 : European Prevalence of Diabetic Patients, by Country, 2017
Table 31 : French Stem Cell Therapy Market, Through 2022
Table 32 : French Stem Cell Research and Services Market, Through 2022
Table 33 : French Stem Cell Cord Blood Services Market, Through 2022
Table 34 : German Stem Cell Therapy Market, Through 2022
Table 35 : German Stem Cell Research and Services Market, Through 2022
Table 36 : German Stem Cell Cord Blood Services Market, Through 2022
Table 37 : Italian Stem Cell Therapy Market, Through 2022
Table 38 : Italian Stem Cell Research and Services Market, Through 2022
Table 39 : Italian Stem Cell Cord Blood Services Market, Through 2022
Table 40 : Spanish Stem Cell Therapy Market, Through 2022
Table 41 : Spanish Stem Cell Research and Services Market, Through 2022
Table 42 : Spanish Stem Cell Cord Blood Services Market, Through 2022
Table 43 : U.K. Stem Cell Therapy Market, Through 2022
Table 44 : U.K. Stem Cell Research and Services Market, Through 2022
Table 45 : U.K. Stem Cell Cord Blood Services Market, Through 2022
Table 46 : China and India Statistics for Cardiovascular Disease, 2016
Table 47 : Asia-Pacific Stem Cell Policies, 2017
Table 48 : Asia-Pacific Stem Cell Market, by Country, Through 2022
Table 49 : Japanese Stem Cell Therapy Market, Through 2022
Table 50 : Japanese Stem Cell Research and Services Market, Through 2022
Table 51 : Japanese Stem Cell Cord Blood Services Market, Through 2022
Table 52 : Chinese Stem Cell Therapy Market, Through 2022
Table 53 : Chinese Stem Cell Research and Services Market, Through 2022
Table 54 : Chinese Stem Cell Cord Blood Services Market, Through 2022
Table 55 : Potential Candidates for Stem Cell Therapy in India, 2016
Table 56 : Indian Stem Cell Therapy Market, Through 2022
Table 57 : Indian Stem Cell Research and Services Market, Through 2022
Table 58 : Indian Stem Cell Cord Blood Services Market, Through 2022
Table 59 : Stem Cell Market in the Rest of the World, Through 2022"

List of Figures
Summary Figure : Global Stem Cell Market, by Region, 2015–2022
Figure 1 : Early Development of Embryo

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • 3Dmatrix
  • Aldagen Inc.
  • Arteriocyte
  • Athersys Inc.
  • Beike Biotechnology Co. Ltd
  • Biotime Inc.
  • Brainstorm Cell Therapeutics Inc.
  • Caladrius Biosciences Inc.
  • Capricor Inc.
  • Cellerant Therapeutics Inc.
  • Cellular Dynamics International
  • Celyad
  • Cytori Therapeutics Inc.
  • Epistem Ltd.
  • Gamida Cell Ltd.
  • Globalstem
  • Hybrid Organ Gmbh
  • International Stem Cell Corporation
  • Juventas Therapeutics Inc.
  • Mesoblast Ltd.
  • Neurogeneration
  • Ocata
  • Osiris Therapeutics Inc.
  • Primegen Biotech Llc
  • Reneuron Group
  • Rhinocyte Inc.
  • Stem Cells Inc.
  • Stemedica Cell Technologies Inc.
  • Stemina Biomarker Discovery Inc.
  • Stempeutics
  • Tigenix NV
  • U.S. Stem Cell Inc.
  • Vericel Corporation
  • Veristem
  • Viacyte Inc.
  • Vitro Diagnostics Inc.
  • Wicell Research Institute
  • Xpand Biotechnology BV
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll